Journals / Üroonkoloji Bülteni / 2020 / Cilt: 19 - Sayı: 3

Evaluation of General Features of Patients with Testicular Cancer

Pages
141–145
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Most of our patients survived during our followup period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Testicular cancers (Tca) are most common in men aged 20-34.
📊
Key Findings & Data:Despite the increase in its incidence, the mortality rate from Tca decreases.
💡
Conclusion & Impact:Most of our patients survived during our followup period.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Testicular cancers (Tca) are most common in men aged 20-34. Despite the increase in its incidence, the mortality rate from Tca decreases. In our study, it was aimed to evaluate the general characteristics, the treatments and survival of the patients who were followed up and treated with the diagnosis of Tca. Materials and Methods: In this study, patients who were admitted to Okmeydanı Training and Research Hospital and Abant İzzet Baysal University, Medical Faculty, Medical Oncology Outpatient Clinic between January 2004 and December 2014 with the diagnosis of Tca, were evaluated retrospectively. Results: In 324 (96.7%) of 332 patients included in the study with the diagnosis of Tca, testicular germ cell tumor (TGCT) was present. Of the patients, 150 (46.3%) had seminoma and 174 (53.7%) had non-seminoma tumors. The median age of patients with TGCT was 32 (minimum 18-maximum 81) years. Non-seminoma group was diagnosed at a younger age (p 0.05). Conclusion: The majority of our patients were diagnosed at an early stage and were in the good prognostic group. Most of our patients survived during our followup period.

🔖

Cite This Article

GÜLSEVEN, M. E., ÜYETÜRK, Ü., GEREDELİ, Ç. (2020). Evaluation of General Features of Patients with Testicular Cancer. Üroonkoloji Bülteni, Cilt: 19 - Sayı: 3, 141–145. https://ajindex.com/articles/334431

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Gilligan T, Lin DW, Aggarwal R, et al. Testicular Cancer, Version 2. 2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17:1529-1554.
  2. Siegel R L, Miller K D, Jemal A. Cancer Statistic, 2020. CA Cancer J Clin 2020;70:7-30.
  3. Shanmugalingam T, Soultati A, Chowdhury S,et al. Global incidence and outcome of testicular cancer. Clin Epidemiol 2013;5:417-427.
  4. Purdue MP, Devesa SS, Sigurdson AJ, et al. International patterns and trends in testis cancer incidence. Int J Cancer 2005;115:822-827.
  5. Chia VM, Quraishi SM, Devesa SS, et al. International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 2010;19:1151-1159.
  6. Honecker F, Aparicio J, Berney D, et al. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol 2018;29:1658-1686.
  7. Vasdev N, Moon A, Thorpe AC. Classification, epidemiology and therapies for testicular germ cell tumours.Int J Dev Biol 2013;57:133-199.
  8. Leman ES, Gonzalgo ML. Prognostic features and markers for testicular cancer management. Indian J Urol 2010;26:76-81.
  9. Magers MJ, Idrees MT. Updates in Staging and Reporting of Testicular Cancer. Surg Pathol Clin 2018;11:813-824.
  10. Heidenreich A, Paffenholz P, Nestler T, Pfister D. European Association of Urology Guidelines on Testis Cancer: Important Take Home Messages.Eur Urol Focus 2019;5:742-744.
  11. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a populationbased to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017;67:93-99. International germ cell cancer collaborative group. International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
  12. Chalya PL, Simbila S, Rambau PF. Ten-year experience with testicular cancer at a tertiary care hospital in a resource-limited setting: a single centre experience in Tanzania.World J Surg Oncol 2014;12:356. Kumar V, Abbas AK, Aster JC. The lower Urinary Tract and Male Genital System. In: Epstein JI, Lotan TL. Pathologic Basis of Disease. 9th Edition, Canada: Elsevier Saunders 2015;972-980.
  13. Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med 2007;131:1267-1280.
  14. Krag Jacobsen G, Barlebo H, Olsen J, et al. Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases. Acta Radiol Oncol 1984;23:239-247.
  15. Wood HM, Elder JS.